Rational modification of hydroxy-functionalized covalent organic frameworks for enhanced photocatalytic hydrogen peroxide evolution.

Covalent organic frameworks (COFs), a class of flexibly tunable crystalline materials, have fascinating potential in photocatalytic hydrogen peroxide (H2O2) evolution under visible light irradiation. However, achieving efficient catalytic activity by tuning the composition of COFs and the linkages of building blocks is still a challenge. Herein, four imine-linked COFs with different numbers of hydroxy-functionalized are constructed to unveil the latent structure-activity relationship between the reversibility of bonding in supramolecular chemistry and the photocatalytic H2O2 performance. As the optimized material, TAPT-HTA-COF (1H-COF) containing single hydroxy group in aldehyde node exhibits a highest ordered structure and conjugation degree along and across the plane in the extended frameworks originating from the flexibly reversible iminol-to-ketoenamine tautomerism than others, which broadens the visible light absorption and accelerates the dissociation of photogenerated carriers in 1H-COF. These merits ensure that 1H-COF has the highest H2O2 yield (44.5 µmol L-1) and O2 two-electron reduction pathway among the four COFs under visible light irradiation (λ > 420 nm, 10 vol% isopropanol aqueous solution). At the same time, the long-range ordered framework of 1H-COF is well preserved during the photocatalytic H2O2 evolution process assisted by the proton-induced tautomerization. This work facilitates the design and development of COF-based photocatalysts in the evolution of H2O2.

Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity.

Alkyl moieties-open chain or cyclic, linear, or branched-are common in drug molecules. The hydrophobicity of alkyl moieties in drug molecules is modified by metabolic hydroxy functionalization via free-radical intermediates to give primary, secondary, or tertiary alcohols depending on the class of the substrate carbon. The hydroxymethyl groups resulting from the functionalization of methyl groups are mostly oxidized further to carboxyl groups to give carboxy metabolites. As observed from the surveyed cases in this review, hydroxy functionalization leads to loss, attenuation, or retention of pharmacologic activity with respect to the parent drug. On the other hand, carboxy functionalization leads to a loss of activity with the exception of only a few cases in which activity is retained. The exceptions are those groups in which the carboxy functionalization occurs at a position distant from a well-defined primary pharmacophore. Some hydroxy metabolites, which are equiactive with their parent drugs, have been developed into ester prodrugs while carboxy metabolites, which are equiactive to their parent drugs, have been developed into drugs as per se. In this review, we present and discuss the above state of affairs for a variety of drug classes, using selected drug members to show the effect on pharmacologic activity as well as dependence of the metabolic change on drug molecular structure. The review provides a basis for informed predictions of (i) structural features required for metabolic hydroxy and carboxy functionalization of alkyl moieties in existing or planned small drug molecules, and (ii) pharmacologic activity of the metabolites resulting from hydroxy and/or carboxy functionalization of alkyl moieties.